| Sherry Bunker, CRNA | |
|
35 Medical Center Pkwy, Augusta, ME 04330-8160 | |
| (207) 626-1000 | |
| Not Available |
| Full Name | Sherry Bunker |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 3 Years |
| Location | 35 Medical Center Pkwy, Augusta, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740848118 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RNA213068 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maine General Medical Center | Augusta, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kennebec Anesthesia Associates Pa | 8325027428 | 35 |
News Archive
Senomyx, Inc., a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that Firmenich SA, the world's largest privately-owned fragrance and flavor company, has made a decision to proceed with commercial development of S6973, Senomyx's enhancer of sucrose (table sugar) that has demonstrated the ability to reduce up to 50% of the sugar in a variety of products while maintaining the taste of natural sugar.
Vertex Pharmaceuticals Incorporated today announced the final results from a Phase 2a study of the investigational selective oral JAK3 inhibitor VX-509.
The Boston Globe examines how Gingrich's view of the individual mandate has changed. Meanwhile, Reuters reports on GOP presidential hopeful Mitt Romney's efforts to keep his record as governor of Massachusetts under wraps. Finally, Rick Santorum gets into a health policy fracas in Iowa.
WellAWARE Systems, the developer of breakthrough technology designed to enable proactive and preventive senior care, announced it was recognized with the 2011 Smart Choice Award presented by the 50+ Housing Council, a special interest council of the Building Industry Association of Southern California.
Endo Pharmaceuticals (Nasdaq: ENDP) announced today the completion of its acquisition of Qualitest Pharmaceuticals. Endo announced Sept. 28 that it entered into a definitive agreement to acquire Qualitest Pharmaceuticals, a leading, privately held generics company in the U.S., for approximately $1.2 billion in cash.
› Verified 1 days ago
| Entity Name | Kennebec Anesthesia Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992789184 PECOS PAC ID: 8325027428 Enrollment ID: O20040714000140 |
News Archive
Senomyx, Inc., a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that Firmenich SA, the world's largest privately-owned fragrance and flavor company, has made a decision to proceed with commercial development of S6973, Senomyx's enhancer of sucrose (table sugar) that has demonstrated the ability to reduce up to 50% of the sugar in a variety of products while maintaining the taste of natural sugar.
Vertex Pharmaceuticals Incorporated today announced the final results from a Phase 2a study of the investigational selective oral JAK3 inhibitor VX-509.
The Boston Globe examines how Gingrich's view of the individual mandate has changed. Meanwhile, Reuters reports on GOP presidential hopeful Mitt Romney's efforts to keep his record as governor of Massachusetts under wraps. Finally, Rick Santorum gets into a health policy fracas in Iowa.
WellAWARE Systems, the developer of breakthrough technology designed to enable proactive and preventive senior care, announced it was recognized with the 2011 Smart Choice Award presented by the 50+ Housing Council, a special interest council of the Building Industry Association of Southern California.
Endo Pharmaceuticals (Nasdaq: ENDP) announced today the completion of its acquisition of Qualitest Pharmaceuticals. Endo announced Sept. 28 that it entered into a definitive agreement to acquire Qualitest Pharmaceuticals, a leading, privately held generics company in the U.S., for approximately $1.2 billion in cash.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sherry Bunker, CRNA 45 Quimby St, Augusta, ME 04330-4436 Ph: (702) 344-8040 | Sherry Bunker, CRNA 35 Medical Center Pkwy, Augusta, ME 04330-8160 Ph: (207) 626-1000 |
News Archive
Senomyx, Inc., a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that Firmenich SA, the world's largest privately-owned fragrance and flavor company, has made a decision to proceed with commercial development of S6973, Senomyx's enhancer of sucrose (table sugar) that has demonstrated the ability to reduce up to 50% of the sugar in a variety of products while maintaining the taste of natural sugar.
Vertex Pharmaceuticals Incorporated today announced the final results from a Phase 2a study of the investigational selective oral JAK3 inhibitor VX-509.
The Boston Globe examines how Gingrich's view of the individual mandate has changed. Meanwhile, Reuters reports on GOP presidential hopeful Mitt Romney's efforts to keep his record as governor of Massachusetts under wraps. Finally, Rick Santorum gets into a health policy fracas in Iowa.
WellAWARE Systems, the developer of breakthrough technology designed to enable proactive and preventive senior care, announced it was recognized with the 2011 Smart Choice Award presented by the 50+ Housing Council, a special interest council of the Building Industry Association of Southern California.
Endo Pharmaceuticals (Nasdaq: ENDP) announced today the completion of its acquisition of Qualitest Pharmaceuticals. Endo announced Sept. 28 that it entered into a definitive agreement to acquire Qualitest Pharmaceuticals, a leading, privately held generics company in the U.S., for approximately $1.2 billion in cash.
› Verified 1 days ago
Stacey C Dostie, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy, Augusta, ME 04330 Phone: 207-622-1959 Fax: 207-430-4007 | |
Vanessa Railton, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy, Augusta, ME 04330 Phone: 207-622-1959 Fax: 207-430-4007 | |
Elisha Rose Coppens, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy # Pa, Augusta, ME 04330 Phone: 207-622-1959 Fax: 207-430-4007 | |
Sharon A Paradis, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 6 E Chestnut St, Augusta, ME 04330 Phone: 207-622-1959 Fax: 207-622-1959 | |
Ms. Edith June St. Pierre, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1 Va Ctr, Augusta, ME 04330 Phone: 207-623-8411 Fax: 207-621-4890 | |
Dana Jo Marshall, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy, Ste 201, Augusta, ME 04330 Phone: 207-622-1959 Fax: 207-430-4007 | |
Michael J Jose, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy Ste 201, Augusta, ME 04330 Phone: 207-622-1959 Fax: 207-430-4007 |